Trial Search Results

Magnetic Resonance Imaging of Breast Cancer

To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)


  • Procedure: MRI





   - Female

   - Documented breast physical examination,

   - Documented mammography within 3 months of the MR studies

   - Palpable or mammographically-detected suspect breast lesions

   - Women who have already undergone lumpectomy for breast cancer and have
   post-biopsy/post-radiation changes will be eligible if they have
   mammographically-detected or palpable breast abnormalities which are sufficiently
   suspicious to merit core needle or surgical biopsy.


   - Male by birth

   - Able to complete the MR examination. Subjects will be interviewed by one of the
   investigators for the usual contraindications to

   - MR contraindications including

   - Pacemakers

   - Metallic implants

   - Severe claustrophobia

   - Aneurysm clips

   - Pregnancy

   - Current lactation

   - Other conditions precluding proximity to a strong magnetic field.

   - Received an enhanced MR procedure within 48 hours,

   - Iodinated contrast within six hours,

   - Known sensitivity to MR contrast agents,

   - Not likely to complete the study in full or

   - Other clinical reason which would preclude participation in the protocol.

Ages Eligible for Study

21 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jocelyn Steffen